EN

简体中文 English
Home

Drug Target Models

GPCR Reporter Cells

Class A（Rhodopsin） Class B1（Secretin） Class C（Glutamate） Combination Orphan and other 7TM Parental Cell

Immunotherapy cells

Fc Effector Combination T Cell Activation Co-Stimulatory Co-Inhibitory Immune Checkpoint STING Cytokine&Growth Factor TAA TLR

Other Stable Cells

Signaling pathway cells Tracer Cell Nuclear Receptor Ion Channel Transporter Other

Assay Kits & Reagents

Assay Kits Reagents

Services

Stable Cell Line Development GPCR Cell-Based Assays Immuno-Oncology Cell Models Kinase Screening Platforms PROTAC Degradation Models ADC Target Cell Models Molecular Biology Services Drug Safety & Toxicology Gene Editing Services

Resources

Product Resource Learning

Company

About Us Careers Conferences&Events Contact us
Home>Drug Target Models>Immunotherapy cells>Combination
Products
GPCR Reporter Cells
Class A（Rhodopsin） Class B1（Secretin） Class C（Glutamate） Combination Orphan and other 7TM Parental Cell
Immunotherapy cells
Combination Fc Effector T Cell Activation Co-Stimulatory Co-Inhibitory Immune Checkpoint STING Cytokine&Growth Factor TAA TLR
Other Stable Cells
Signaling pathway cells Tracer Cell Nuclear Receptor Ion Channel Transporter Other
Assay Kits & Reagents
Assay Kits Reagents

We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, and HEK293 Cell Lines Officially Secured.

Explore

Combination

Description
Product list

Description

Our platform provides engineered cellular models covering multi-pathway combinations including PD-1, CTLA4, TIGIT, LAG3, 41BB, OX40, and SIRPα/CD47. Utilizing dual-reporter systems and antigen-presenting cell platforms, these models enable simultaneous evaluation of immune checkpoint synergy, antibody efficacy, and immune cell activation, offering physiologically relevant in vitro tools for developing combination immunotherapy.

Product list

Target:
Item number
Cell name
Details
加载更多

Contact us

Name

Phone

Email*

Service & Products Interested*

Comments

submit